CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Promisemed Hangzhou Meditech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Promisemed Hangzhou Meditech Co Ltd
Phone: +86 57188562639p:+86 57188562639 HANGZHOU, ZHJ  311121  China Ticker: 920069920069

Business Summary
Promisemed Hangzhou Meditech Co Ltd is a China-based company engaged in the research, development, production and sales of diabetes care, general administration and infusion, and minimally invasive intervention medical devices. The Company aims to diagnose and treat chronic diseases such as diabetes, tumor and digestive tract diseases. The Company's diabetes care products include insulin pen needles, insulin syringes, peripheral blood collection needles, accessories and other product series. The Company's general drug infusion products include safety needles, syringes, venous blood collection needles, vascular access and other product series. The minimally invasive intervention products include various biopsy needles, disposable endoscopic intervention consumables, and others.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202512/31/2024-----

General Information
Number of Employees: 474 (As of 6/30/2025)
Outstanding Shares: 52,914,000 (As of 3/27/2026)
Stock Exchange: BJS
Fax Number: +86 57188772985


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 10, 2026